With vanadyl sulphate being like IGF-1, we expected to see resistance in the diabetic animals, but we didn't see that. We saw similar improvement. Thus it must have been acting through a different pathway than do IGF-1 or insulin.

-Daniel Johnson

Select a background
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image

More quotes by Daniel Johnson